drugset / Trial / NCT00624416
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of isoproterenol and prednisolone will shrink the size of lipomas, which are benign fatty tumors.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoproterenol | Small molecule | 0.04 mg | Subcutaneous |
| Subject | Isoproterenol | Small molecule | 0.08 mg | Subcutaneous |
| Subject | Prednisolone | Other / unclassified | 0.07 mg | Subcutaneous |
| Subject | Prednisolone | Other / unclassified | 0.14 mg | Subcutaneous |